Bharat Book Bureau Provides the Trending Market Research Report on “Global Biosimulation Market Forecast to 2022” under Life Sciences. The report provides information on industry overview, market size, latest developments, industry trends, Key players, global presence, and their future prospects.
Global biosimulation market projected to grow at a CAGR of 15.9%
The biosimulation market is expected to reach USD 2.88 billion by 2022 from USD 1.38 billion in 2017, at a CAGR of 15.9%. Increase in R&D investments in the pharmaceutical and biotechnology industries, growing adoption of biosimulation software by regulatory bodies, technologically advanced QSP systems, need to curtail drug discovery and development costs, and growth in the biologics and biosimilars markets are driving the growth of the biosimulation market. On the other hand, market growth may be limited to a certain extent due to the lack of standardization for biosimulation solutions.
Biosimulation services are expected to grow at the highest CAGR during the forecast period
By product and service, the biosimulation market is segmented into software and services. The biosimulation services segment is projected to register the highest CAGR during the forecast period. The high growth in this segment is attributed to the recurring need for services such as data analysis, and consulting services.
Ownership models segment is expected to dominate the market during the forecast period
Request a Sample copy of Global Biosimulation Market Report @ https://www.bharatbook.com/request-sample/345478
Based on the delivery model, the biosimulation market is segmented into ownership models and subscription models. The ownership models segment is expected to dominate the market during the forecast period. Buyers mainly opt for these delivery models due to the security benefits associated with them are the major factors that are supporting the growth of this delivery models segment.
Europe to witness high growth during the forecast period
In 2017, North America is expected to account for the largest share of the market followed by Europe. However, Europe is expected to register the highest CAGR during the forecast period. The growing focus on research-related funding activities by governments is expected to assist in the development of drug discovery and development process, thus driving the demand for biosimulation in the European region.
The primary interviews conducted for this report can be categorized as follows:
Global biosimulation market projected to grow at a CAGR of 15.9%
The biosimulation market is expected to reach USD 2.88 billion by 2022 from USD 1.38 billion in 2017, at a CAGR of 15.9%. Increase in R&D investments in the pharmaceutical and biotechnology industries, growing adoption of biosimulation software by regulatory bodies, technologically advanced QSP systems, need to curtail drug discovery and development costs, and growth in the biologics and biosimilars markets are driving the growth of the biosimulation market. On the other hand, market growth may be limited to a certain extent due to the lack of standardization for biosimulation solutions.
Biosimulation services are expected to grow at the highest CAGR during the forecast period
By product and service, the biosimulation market is segmented into software and services. The biosimulation services segment is projected to register the highest CAGR during the forecast period. The high growth in this segment is attributed to the recurring need for services such as data analysis, and consulting services.
Ownership models segment is expected to dominate the market during the forecast period
Request a Sample copy of Global Biosimulation Market Report @ https://www.bharatbook.com/request-sample/345478
Based on the delivery model, the biosimulation market is segmented into ownership models and subscription models. The ownership models segment is expected to dominate the market during the forecast period. Buyers mainly opt for these delivery models due to the security benefits associated with them are the major factors that are supporting the growth of this delivery models segment.
Europe to witness high growth during the forecast period
In 2017, North America is expected to account for the largest share of the market followed by Europe. However, Europe is expected to register the highest CAGR during the forecast period. The growing focus on research-related funding activities by governments is expected to assist in the development of drug discovery and development process, thus driving the demand for biosimulation in the European region.
The primary interviews conducted for this report can be categorized as follows:
- By Company Type: Tier 1 – 62%; Tier 2 - 25%; Tier 3 - 13%.
- By Designation: C-level- 29%; D-level- 25%; Others-46%.
- By Region: North America-55%; Europe-24%; Asia-15%; RoW-6%.
List of companies profiled in the report
- Certara (US)
- Simulations Plus (US)
- Dassault Systèmes (France)
- Schrödinger (US)
- ACD/Labs (Canada)
- Chemical Computing Group (Canada)
- Physiomics (UK)
- Evidera (US)
- In silico biosciences (US)
- INOSIM Software (Germany)
- Insilico Biotechnology (Germany)
- LeadInvent Technologies (India)
- Rosa (US)
- Nuventra Pharma (US)
- Genedata (Switzerland)
To browse full research report with TOC, click the link below :
https://www.bharatbook.com/biotechnology-market-research-reports-345478/biosimulation-software-molecular-simulation.html
About Bharat Book Bureau :
Bharat Book Bureau is the leading market research information provider for market research reports, company profiles, industry study, country reports, business reports, newsletters and online databases Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. We cover sectors starting from Aeronautics to Zoology.
Contact us at :
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Email: poonam@bharatbook.com
Website: www.bharatbook.com
Follow us on : Twitter, Facebook, Linkedin, Google Plus
List of companies profiled in the report
- Certara (US)
- Simulations Plus (US)
- Dassault Systèmes (France)
- Schrödinger (US)
- ACD/Labs (Canada)
- Chemical Computing Group (Canada)
- Physiomics (UK)
- Evidera (US)
- In silico biosciences (US)
- INOSIM Software (Germany)
- Insilico Biotechnology (Germany)
- LeadInvent Technologies (India)
- Rosa (US)
- Nuventra Pharma (US)
- Genedata (Switzerland)
To browse full research report with TOC, click the link below :
https://www.bharatbook.com/biotechnology-market-research-reports-345478/biosimulation-software-molecular-simulation.html
About Bharat Book Bureau :
Bharat Book Bureau is the leading market research information provider for market research reports, company profiles, industry study, country reports, business reports, newsletters and online databases Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. We cover sectors starting from Aeronautics to Zoology.
Contact us at :
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Email: poonam@bharatbook.com
Website: www.bharatbook.com
Follow us on : Twitter, Facebook, Linkedin, Google Plus
Comments
Post a Comment